Better Science, Better Health: New Healthcare Models Join the conversation on twitter #BSBH15 Agenda: October 26th, 2015, Washington DC Hotel George 7:00 pm Cocktail Reception Kindly sponsored by Pfizer & DIA October 27th, 2015, Washington DC Cannon House Office Building, Cannon Caucas Room 8:00- 9:00 [...]
Washington DC, 27th - 28th October 2015
An International Gathering of the World’s Thought Leaders in New Healthcare Models.
Supported by:
Sponsored by:
Steven Whitehead Chief Executive, ABPI Stephen Whitehead is Chief Executive of the ABPI and is the chief advocate for the research-based industry in the UK. His career has centred on communications and policy and he is a regular speaker at industry and NHS conferences. Stephen has a strong personal passion and commitment to the pharmaceutical [...]
Geoff Wilson HTA Task Force Leadership Member, COCIR Geoff currently works for GE Healthcare as Global HTA Leader and is interested in all aspects of Health Technology Assessment (HTA) for medical imaging equipment, medical devices and healthcare IT and demonstrating value to support optimal payment for procedures wherever these are carried out – in hospitals [...]
Tim Williams Head of Research, Clinical Practice Research Datalink (CPRD) Dr Tim Williams is a Head of Research within the formed Clinical Practice Research Datalink (CPRD) within the Medicines and Healthcare products Regulatory Agency (MHRA). He has an MSc in Epidemiology from London School of Hygiene and Tropical Medicine and PhD in biomedical computing from [...]
Andrew Ward Pharmaceuticals Correspondent, Financial Times Andrew Ward is the FT’s pharmaceuticals correspondent from January 2014. In this role, he will cover the business, politics, science and development aspects of the global pharmaceuticals industry. Prior to this, Ward had been UK news editor since November 2011. Previously, Ward served the FT in a number of [...]
Bart Vannieuwenhuyse Senior Director Health Information Sciences, Janssen Pharmaceuticals In 1985, Bart joined Janssen Pharmaceutica as a clinical trial monitor. In the course of his career with Janssen, Bart has held a variety of marketing and sales positions, both at local operating company level (e.g. the Netherlands) and at international level. While in the Netherlands [...]
Mark Trusheim Executive-in-Residence, MIT Mark Trusheim is the Bio-manufacturing Executive in Residence at the University of Massachusetts Dartmouth and a member of the Massachusetts Bio-Manufacturing Roundtable. In 2004 as Interim President and Board Member of the Massachusetts Biotechnology Council, Mark began working with the University of Massachusetts to develop public, private collaborations as part of [...]
Richard Torbett Chief Economist, EFPIA Richard Torbett is Chief Economist at EFPIA. He is responsible for economic analysis as well as EFPIA’s relations with international economic institutions, notably the so-called Troika – the International Monetary Fund, the European Commission’s DG Economic and Financial Affairs (ECFIN) and the European Central Bank. Richard’s current work focuses on [...]
Sir Richard Thompson Immediate Past President, Royal College of Physicians Sir Richard trained in natural sciences and medicine at Oxford and St Thomas' Hospital Medical School. After junior posts in London, he joined Dr Roger Williams in the early days of the liver unit at King's College Hospital, and spent 18 months with Professor Alan [...]